Vir Biotechnology, Inc. VIR Q2 2025 earnings
Reported August 6, 2025 · After market close
Revenue$1.2MMiss by $1.5M
EPS-$0.80Miss by $0.08
Revenue estimate$2.7M
EPS estimate-$0.72
Next report
Aug 5, 2026 (In 1 week)Revenue estimate$135.9M
EPS estimate$0.33
Financials
Q2 2025Valuation & ratios
Versus estimates
Revenue
Diluted EPS
Ask the moment Vir Biotechnology, Inc. reports.
Connect your AI and ask the moment the filing drops. It reads the release, surfaces what management said, and gives you its own read.
Connect your AI
Claude
Questions, answered.
- When did Vir Biotechnology, Inc. report Q2 2025 earnings?
- Vir Biotechnology, Inc. (VIR) reported Q2 2025 earnings on August 6, 2025 after market close.
- What were Vir Biotechnology, Inc.'s Q2 2025 revenue and EPS?
- Vir Biotechnology, Inc. reported revenue of $1.2M and eps of $-0.80 for Q2 2025.
- Did Vir Biotechnology, Inc. beat estimates in Q2 2025?
- Revenue missed the consensus estimate of $2.7M by $1.5M. EPS missed the consensus estimate of $-0.72 by $0.08.
- How did Vir Biotechnology, Inc.'s Q2 2025 results compare year-over-year?
- Compared to the same quarter a year prior, revenue declined 60.5% from $3.1M a year earlier and eps grew 21.6% from $-1.02.
- Where can I find Vir Biotechnology, Inc.'s Q2 2025 SEC filings?
- You can read the 10-Q periodic report (0001628280-25-038431) directly on SEC EDGAR. The filing index links above go to sec.gov.